Types of cervical epidural steroid injections

Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Many of the drugs used in the standard treatment are being tested in different combinations and doses. TREATMENT FOLLOW-UP

  • A Pap smear and careful examination of the pelvis, abdomen and lymph nodes is performed every three months for the first two years after treatment, and then every six months for three more years.
  • Routine chest x-rays and pelvic and abdominal CT scans are not warranted in the absence of symptoms.
  • The serum levels of carcinoembryonic antigen and/or squamous cell carcinoma antigen in the blood should be measured at each visit if they were elevated before treatment.
RECURRENT CANCER Symptoms of recurrent cervical carcinoma may include vaginal bleeding or discharge, pain in the pelvis, back or legs, leg swelling (edema), chronic cough and weight loss.
  • Cervical cancer can recur in the vagina, pelvis, lymph nodes, lung, or liver.
  • If radiation was not given previously, recurrences that are confined to the pelvis may be treated with external beam radiation with chemotherapy and intracavitary or interstitial radiation therapy.
  • If radiation therapy was already given, the only option is the removal of the vagina, uterus, and the bladder and/or rectum with the creation of an artificial bladder-a pelvic exenteration. The five-year survival rate after a pelvic exenteration is about 50 percent.
  • Women with recurrent tumors that cannot be surgically removed or with metastatic disease are usually treated with chemotherapy. Commonly used drugs include single agent cisplatin or carboplatin. Other regimens include cisplatin or carboplatin + ifosfamide, vincristine + mitomycin-C + bleomycin + cisplatin and bleomycin + mitomycin-C + 5-fluorouracil.
  • Those with unresectable pelvic disease may be re-irradiated with interstitial radiation or given pelvic arterial chemotherapy.
  • What qualification do you have for treating cancer
  • Will a specialist in gynecologic oncology be involved in my care?
  • What is the advantage of surgery versus radiation therapy?
  • Why or why not, will a staging surgery be performed?
  • Is there a benefit of using high-dose rate radiation therapy?
Additional online resources for information on Cervical Cancer .

Cervical cancer is the 7th most common cause of cancer death in Europe for females, and the 15th most common cause of cancer death overall, with around 24,400 deaths from cervical cancer in 2012 (3% of female deaths and 1% of the total). In Europe (2012), the highest World age-standardised mortality rates for cervical cancer are in Romania; the lowest rates are in Iceland. UK cervical cancer mortality rates are estimated to be the 9th lowest in Europe.[ 1 ] These data are broadly in line with Europe-specific data available elsewhere.[ 2 ]

Types of cervical epidural steroid injections

types of cervical epidural steroid injections


types of cervical epidural steroid injectionstypes of cervical epidural steroid injectionstypes of cervical epidural steroid injectionstypes of cervical epidural steroid injectionstypes of cervical epidural steroid injections